Innate Pharma SA logo

Innate Pharma SA - Class A

XPAR:IPH (France)   Class A
€ 2.21 (+0.68%) May 3
At Loss
P/B:
3.43
Market Cap:
€ 178.26M ($ 192.01M)
Enterprise V:
€ 125.69M ($ 134.09M)
Volume:
42.19K
Avg Vol (2M):
57.43K
Also Trade In:
Volume:
42.19K
At Loss
Avg Vol (2M):
57.43K

Innate Pharma SA (XPAR:IPH) Stock News, Headlines & Updates

Innate Pharma SA Stock News from GuruFocus

Total 24
  • 1
Apr 15, 2024
Apr 10, 2024
Apr 09, 2024
Apr 05, 2024
Mar 19, 2024
Mar 14, 2024
Mar 06, 2024
Feb 21, 2024
Feb 07, 2024
Innate Pharma SA KOL Event Transcript
GuruFocus Research • 10:00am
Q1 2023 Innate Pharma SA Earnings Call Transcript
GuruFocus Research • 10:00am
Q4 2022 Innate Pharma SA Earnings Call Transcript
GuruFocus Research • 10:00am
Q3 2022 Innate Pharma SA Earnings Call Transcript
GuruFocus Research • 10:00am
Q2 2022 Innate Pharma SA Earnings Call Transcript
GuruFocus Research • 10:00am
Q1 2022 Innate Pharma SA Earnings Call Transcript
GuruFocus Research • 10:00am
Q4 2021 Innate Pharma SA Earnings Call Transcript
GuruFocus Research • 10:00am
Q2 2021 Innate Pharma SA Earnings Call Transcript
GuruFocus Research • 10:00am
Q1 2021 Innate Pharma SA Earnings Call Transcript
GuruFocus Research • 10:00am
Q4 2020 Innate Pharma SA Earnings Call Transcript
GuruFocus Research • 10:00am
Total 24
  • 1
Show
Entries

Headlines

Total 0
  • 1
No recent news